FDA panel votes against approval for bivalirudin.

作者信息

Piña I

机构信息

Department of Cardiology, Temple University, Philadelphia, Pa, USA.

出版信息

Circulation. 1999 Mar 16;99(10):1277. doi: 10.1161/01.cir.99.10.1277.

DOI:10.1161/01.cir.99.10.1277

PMID:10077507

Abstract

摘要

相似文献

FDA panel votes against approval for bivalirudin.

Circulation. 1999 Mar 16;99(10):1277. doi: 10.1161/01.cir.99.10.1277.

Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.

Am Heart J. 2002 Feb;143(2):189-92. doi: 10.1067/mhj.2002.120407.

Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.

Hamostaseologie. 2002 Aug;22(3):60-6.

Bivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial Infarction.

Am Heart J. 2002 Feb;143(2):229-34. doi: 10.1067/mhj.2002.120405.

Bivalirudin: a direct thrombin inhibitor.

Clin Ther. 2002 Jan;24(1):38-58. doi: 10.1016/s0149-2918(02)85004-4.

Publication policy, informed consent, and the randomized clinical trial.

Am Heart J. 2002 Feb;143(2):187-8. doi: 10.1067/mhj.2002.120406.

Bivalirudin (Angiomax) for angioplasty.

Med Lett Drugs Ther. 2001 Apr 30;43(1103):37-8.

Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention.

J Invasive Cardiol. 2000 Dec;12 Suppl F:14F-9.

Caspofungin acetate, bivalirudin.

Am J Health Syst Pharm. 2001 Oct 1;58(19):1807-9. doi: 10.1093/ajhp/58.19.1807.

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

Am J Cardiol. 2004 May 1;93(9):1092-6. doi: 10.1016/j.amjcard.2004.01.033.

引用本文的文献

Recombinant neorudin and its active metabolite hirudin: the fate of a novel anticoagulant drug.

Front Pharmacol. 2024 Sep 17;15:1443475. doi: 10.3389/fphar.2024.1443475. eCollection 2024.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验